The Experts below are selected from a list of 203580 Experts worldwide ranked by ideXlab platform
Seth R Schwartz - One of the best experts on this subject based on the ideXlab platform.
-
Clinical Practice Guideline benign paroxysmal positional vertigo update executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Neil Bhattacharyya, Seth R Schwartz, Samuel P Gubbels, Jonathan A Edlow, Hussam K Elkashlan, Terry D Fife, Janene M Holmberg, Kathryn Mahoney, Deena B Hollingsworth, Richard RobertsAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the “Clinical Practice Guideline: ...
-
Clinical Practice Guideline benign paroxysmal positional vertigo update executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Neil Bhattacharyya, Seth R Schwartz, Samuel P Gubbels, Jonathan A Edlow, Hussam K Elkashlan, Terry D Fife, Janene M Holmberg, Kathryn Mahoney, Deena B Hollingsworth, Richard A RobertsAbstract:The American Academy of Otolaryngology-Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology-Head and Neck Surgery featuring the "Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)." To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 recommendations developed emphasize diagnostic accuracy and efficiency, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing, and increasing the appropriate therapeutic repositioning maneuvers. An updated Guideline is needed due to new Clinical trials, new systematic reviews, and the lack of consumer participation in the initial Guideline development group.
-
Clinical Practice Guideline update earwax cerumen impaction
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:ObjectiveThis update of the 2008 American Academy of Otolaryngology—Head and Neck Surgery Foundation cerumen impaction Clinical Practice Guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior Guideline includea consumer added to the development group;new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials);enhanced information on patient education and counseling;a new algorithm to clarify action statement relationships;expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion;an enhanced external review process to include public comment and journal peer review; and3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and ...
-
Clinical Practice Guideline update earwax cerumen impaction executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the updated Clinical Practice Guideline: Earwax (Cerumen Impaction). To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 11 recommendations emphasize proper ear hygiene, diagnosis of cerumen impaction, factors that modify management, evaluating the need for intervention, and proper treatment. An updated Guideline is needed due to new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials) and the need to add statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care.
-
Clinical Practice Guideline Allergic Rhinitis Executive Summary
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015Co-Authors: Michael D. Seidman, Seth R Schwartz, Jesse M Hackell, Richard K. Gurgel, Sandra Y. Lin, Fuad M. Baroody, James R. Bonner, Douglas E Dawson, Mark S. Dykewicz, Joseph K. HanAbstract:The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue featuring the new Clinical Practice Guideline: Allergic Rhinitis. To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 recommendations developed address the evaluation of patients with allergic rhinitis, including performing and interpretation of diagnostic testing and assessment and documentation of chronic conditions and comorbidities. It will then focus on the recommendations to guide the evaluation and treatment of patients with allergic rhinitis, to determine the most appropriate interventions to improve symptoms and quality of life for patients with allergic rhinitis.
Richard M Rosenfeld - One of the best experts on this subject based on the ideXlab platform.
-
Clinical Practice Guideline update earwax cerumen impaction
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:ObjectiveThis update of the 2008 American Academy of Otolaryngology—Head and Neck Surgery Foundation cerumen impaction Clinical Practice Guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior Guideline includea consumer added to the development group;new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials);enhanced information on patient education and counseling;a new algorithm to clarify action statement relationships;expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion;an enhanced external review process to include public comment and journal peer review; and3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and ...
-
Clinical Practice Guideline update earwax cerumen impaction executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the updated Clinical Practice Guideline: Earwax (Cerumen Impaction). To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 11 recommendations emphasize proper ear hygiene, diagnosis of cerumen impaction, factors that modify management, evaluating the need for intervention, and proper treatment. An updated Guideline is needed due to new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials) and the need to add statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care.
-
Clinical Practice Guideline update adult sinusitis executive summary
Otolaryngology-Head and Neck Surgery, 2015Co-Authors: Richard M Rosenfeld, Sujana S. Chandrasekhar, Jay F Piccirillo, Itzhak Brook, Kaparaboyna Ashok Kumar, Maggie A Kramper, Richard R Orlandi, James N Palmer, Zara M Patel, Anju T PetersAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation has published a supplement to this issue featuring the updated “Clinical Practice Guideline: Adult Sinusitis” as a supplement to Otolaryngology–Head and Neck Surgery. To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 developed recommendations address diagnostic accuracy for adult rhinosinusitis, the appropriate use of ancillary tests to confirm diagnosis and guide management (including radiography, nasal endoscopy, computed tomography, and testing for allergy and immune function), and the judicious use of systemic and topical therapy. Emphasis was also placed on identifying multiple chronic conditions that would modify management of rhinosinusitis, including asthma, cystic fibrosis, immunocompromised state, and ciliary dyskinesia. An updated Guideline is needed as a result of new Clinical trials, new systematic reviews, and the lack of consumer participation in the initial Guideline development group.
-
Clinical Practice Guideline: Tinnitus Executive Summary
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014Co-Authors: David E. Tunkel, Richard M Rosenfeld, Carol A. Bauer, Gordon H. Sun, Sujana S. Chandrasekhar, Eugene R. Cunningham, Sanford M. Archer, Brian W. Blakley, John M. Carter, Evelyn C. GranieriAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue featuring the new Clinical Practice Guideline: Tinnitus. To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 13 recommendations developed address the evaluation of patients with tinnitus, including selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology. It will then focus on the evaluation and treatment of patients with persistent primary tinnitus, with recommendations to guide the evaluation and measurement of the impact of tinnitus and to determine the most appropriate interventions to improve symptoms and quality of life for tinnitus sufferers.
-
Clinical Practice Guideline on adult sinusitis
Otolaryngology-Head and Neck Surgery, 2007Co-Authors: Richard M RosenfeldAbstract:This executive summary will alert clinicians to key evidence-based statements in a multidisciplinary, Clinical Practice Guideline on adult sinusitis developed by the American Academy of Otolaryngology-Head and Neck Surgery Foundation. Included in the Guideline are 17 boldfaced action statements: 3 on viral rhinosinusitis, 7 on acute bacterial rhinosinusitis, and 7 on chronic rhinosinusitis and recurrent acute rhinosinusitis. Evidence profiles that accompany each statement are summarized to show why it was made and how it can be implemented. Guideline statements regarding acute rhinosinusitis focus on diagnosing presumed bacterial illness and using antibiotics appropriately. Guideline statements regarding chronic rhinosinusitis or recurrent acute rhinosinusitis focus on appropriate use of diagnostic tests. Surgical therapy is not discussed.
Sandy Walsh - One of the best experts on this subject based on the ideXlab platform.
-
Clinical Practice Guideline update earwax cerumen impaction
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:ObjectiveThis update of the 2008 American Academy of Otolaryngology—Head and Neck Surgery Foundation cerumen impaction Clinical Practice Guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior Guideline includea consumer added to the development group;new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials);enhanced information on patient education and counseling;a new algorithm to clarify action statement relationships;expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion;an enhanced external review process to include public comment and journal peer review; and3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and ...
-
Clinical Practice Guideline update earwax cerumen impaction executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the updated Clinical Practice Guideline: Earwax (Cerumen Impaction). To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 11 recommendations emphasize proper ear hygiene, diagnosis of cerumen impaction, factors that modify management, evaluating the need for intervention, and proper treatment. An updated Guideline is needed due to new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials) and the need to add statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care.
Jesse M Hackell - One of the best experts on this subject based on the ideXlab platform.
-
Clinical Practice Guideline update earwax cerumen impaction
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:ObjectiveThis update of the 2008 American Academy of Otolaryngology—Head and Neck Surgery Foundation cerumen impaction Clinical Practice Guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior Guideline includea consumer added to the development group;new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials);enhanced information on patient education and counseling;a new algorithm to clarify action statement relationships;expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion;an enhanced external review process to include public comment and journal peer review; and3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and ...
-
Clinical Practice Guideline update earwax cerumen impaction executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the updated Clinical Practice Guideline: Earwax (Cerumen Impaction). To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 11 recommendations emphasize proper ear hygiene, diagnosis of cerumen impaction, factors that modify management, evaluating the need for intervention, and proper treatment. An updated Guideline is needed due to new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials) and the need to add statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care.
-
Clinical Practice Guideline Allergic Rhinitis Executive Summary
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015Co-Authors: Michael D. Seidman, Seth R Schwartz, Jesse M Hackell, Richard K. Gurgel, Sandra Y. Lin, Fuad M. Baroody, James R. Bonner, Douglas E Dawson, Mark S. Dykewicz, Joseph K. HanAbstract:The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue featuring the new Clinical Practice Guideline: Allergic Rhinitis. To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 recommendations developed address the evaluation of patients with allergic rhinitis, including performing and interpretation of diagnostic testing and assessment and documentation of chronic conditions and comorbidities. It will then focus on the recommendations to guide the evaluation and treatment of patients with allergic rhinitis, to determine the most appropriate interventions to improve symptoms and quality of life for patients with allergic rhinitis.
-
Clinical Practice Guideline allergic rhinitis
Otolaryngology-Head and Neck Surgery, 2015Co-Authors: Michael D. Seidman, Seth R Schwartz, Jesse M Hackell, Richard K. Gurgel, Sandra Y. Lin, Fuad M. Baroody, James R. Bonner, Douglas E Dawson, Mark S. Dykewicz, Joseph K. HanAbstract:Objective. Allergic rhinitis (AR) is one of the most common diseases affecting adults. It is the most common chronic disease in children in the United States today and the fifth most common chronic disease in the United States overall. AR is estimated to affect nearly 1 in every 6 Americans and generates $2 to $5 billion in direct health expenditures annually. It can impair quality of life and, through loss of work and school attendance, is responsible for as much as $2 to $4 billion in lost productivity annually. Not surprisingly, myriad diagnostic tests and treatments are used in managing this disorder, yet there is considerable variation in their use. This Clinical Practice Guideline was undertaken to optimize the care of patients with AR by addressing quality improvement opportunities through an evaluation of the available evidence and an assessment of the harm-benefit balance of various diagnostic and management options. Purpose. The primary purpose of this Guideline is to address quality improvement opportunities for all clinicians, in any setting, who are likely to manage patients with AR as well as to optimize patient care, promote effective diagnosis and therapy, and reduce harmful or unnecessary variations in care. The Guideline is intended to be applicable for both pediatric and adult patients with AR. Children under the age of 2 years were excluded from the Clinical Practice Guideline because rhinitis in this population may be different than in older patients and is not informed by the same evidence base. The Guideline is intended to focus on a limited number of quality improvement opportunities deemed most important by the working group and is not intended to be a comprehensive reference for diagnosing and managing AR. The recommendations outlined in the Guideline are not intended to represent the standard of care for patient management, nor are the recommendations intended to limit treatment or care provided to individual patients. Action Statements. The development group made a strong recommendation that clinicians recommend intranasal steroids for patients with a Clinical diagnosis of AR whose symptoms affect their quality of life. The development group also made a strong recommendation that clinicians recommend oral second-generation/less sedating antihistamines for patients with AR and primary complaints of sneezing and itching. The panel made the following recommendations: (1) Clinicians should make the Clinical diagnosis of AR when patients present with a history and physical examination consistent with an allergic cause and 1 or more of the following symptoms: nasal congestion, runny nose, itchy nose, or sneezing. Findings of AR consistent with an allergic cause include, but are not limited to, clear rhinorrhea, nasal congestion, pale discoloration of the nasal mucosa, and red and watery eyes. (2) Clinicians should perform and interpret, or refer to a clinician who can perform and interpret, specific IgE (skin or blood) allergy testing for patients with a Clinical diagnosis of AR who do not respond to empiric treatment, or when the diagnosis is uncertain, or when knowledge of the specific causative allergen is needed to target therapy. (3) Clinicians should assess patients with a Clinical diagnosis of AR for, and document in the medical record, the presence of associated conditions such as asthma, atopic dermatitis, sleep-disordered breathing, conjunctivitis, rhinosinusitis, and otitis media. (4) Clinicians should offer, or refer to a clinician who can offer, immunotherapy (sublingual or subcutaneous) for patients with AR who have inadequate response to symptoms with pharmacologic therapy with or without environmental controls.
Anthony E. Magit - One of the best experts on this subject based on the ideXlab platform.
-
Clinical Practice Guideline update earwax cerumen impaction
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:ObjectiveThis update of the 2008 American Academy of Otolaryngology—Head and Neck Surgery Foundation cerumen impaction Clinical Practice Guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior Guideline includea consumer added to the development group;new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials);enhanced information on patient education and counseling;a new algorithm to clarify action statement relationships;expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion;an enhanced external review process to include public comment and journal peer review; and3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and ...
-
Clinical Practice Guideline update earwax cerumen impaction executive summary
Otolaryngology-Head and Neck Surgery, 2017Co-Authors: Seth R Schwartz, Bopanna B Ballachanda, Jesse M Hackell, Helene J Krouse, Claire M Lawlor, Kourosh Parham, David R Stutz, Richard M Rosenfeld, Anthony E. Magit, Sandy WalshAbstract:The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue of Otolaryngology–Head and Neck Surgery featuring the updated Clinical Practice Guideline: Earwax (Cerumen Impaction). To assist in implementing the Guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 11 recommendations emphasize proper ear hygiene, diagnosis of cerumen impaction, factors that modify management, evaluating the need for intervention, and proper treatment. An updated Guideline is needed due to new evidence (3 Guidelines, 5 systematic reviews, and 6 randomized controlled trials) and the need to add statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care.